A carregar...
Rituximab in Membranous Nephropathy: Not all studies are created equal
Many prospective studies and a recent randomized controlled trial have shown that the B-cell depleting monoclonal antibody rituximab safely promotes remission of nephrotic syndrome in approximately 65% of patients with membranous nephropathy (MN). Mechanistic studies have indicated that rituximab-in...
Na minha lista:
| Publicado no: | Nephron |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5214174/ https://ncbi.nlm.nih.gov/pubmed/27676651 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000450659 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|